Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ribonucleases: from prototypes to therapeutic targets?

Stefan Loverix1, Jan Steyaert

  • 1Vlaams Interuniversitair Instituut Biotechnologie (VIB), Instituut voor Moleculaire Biologie, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussel, Belgium. sloverix@vub.ac.be

Current Medicinal Chemistry
|April 8, 2003
PubMed
Summary

Ribonucleases (RNases) are crucial for RNA regulation and disease. This review explores RNase A and T1 structures to design effective small-molecule inhibitors for therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural basis for activation and potentiation in a human α5β3 GABA<sub>A</sub> receptor.

Nature communications·2026
Same author

Structural and functional characterisation of the Crimean-Congo haemorrhagic fever virus RNA dependent RNA polymerase.

Nature communications·2026
Same author

Is capacity to consent to healthcare a uniformly defined concept? Insights from a document analysis of laws and national guidelines across six European countries.

International journal of law and psychiatry·2026
Same author

Design principles of a membrane-spanning ubiquitin ligase.

Molecular cell·2026
Same author

Nanobody-mediated control of long RSH Rel and RelA catalysis by restriction of their conformational landscape.

Nature communications·2026
Same author

Structurally exclusive Teneurin complexes orchestrate divergent programs in early cortical development.

Nature communications·2026

Area of Science:

  • Biochemistry and Molecular Biology
  • Enzymology
  • Structural Biology

Background:

  • Ribonucleases (RNases) are key regulators of cellular RNA populations.
  • RNase activity is implicated in various diseases, including cancers and infections.
  • Existing RNase inhibitors show limited efficacy, binding in the micromolar range.

Purpose of the Study:

  • To review the chemical and structural features of RNase A and RNase T1.
  • To inform the rational design of novel, potent RNase transition state analog inhibitors.
  • To address the lack of clinically available drugs targeting RNases.

Main Methods:

  • Literature review focusing on RNase A and RNase T1.
  • Analysis of enzyme-substrate interactions and transition state properties.

Related Experiment Videos

  • Comparative study of structural homology and functional relevance.

    • Main Results:

    • RNase A and T1 are well-characterized models for RNase research.
    • Current inhibitors exhibit suboptimal binding affinities compared to theoretical transition states.
    • Understanding precise transition state nature is critical for inhibitor design.

    Conclusions:

    • Detailed knowledge of RNase A and T1 structures and interactions is essential for developing effective inhibitors.
    • Targeting RNases holds therapeutic potential for various diseases.
    • Further research into transition state analogs could yield picomolar inhibitors.